Last reviewed · How we verify
NCT03989076
Inferior Vena Cava (IVC) Diameters Before & After Interscalene Block
trial testing Interscalene Brachial Plexus Block in IVC - Inferior Vena Cava Abnormality. Withdrawn.
14 July 2021
Quick facts
| Lead sponsor | University of California, San Diego |
|---|---|
| Status | Withdrawn |
| Study type | OBSERVATIONAL |
| Start date | 12 April 2019 |
| Primary completion | 14 July 2021 |
| Estimated completion | 14 July 2021 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Interscalene Brachial Plexus Block
Conditions studied
- IVC - Inferior Vena Cava Abnormality — all drugs for IVC - Inferior Vena Cava Abnormality →
Sponsor
University of California, San Diego
Who can join
18 and older, any sex, with IVC - Inferior Vena Cava Abnormality. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to understand how changes to breathing patterns in the chest affect blood flow to the heart from the inferior vena cava in the abdomen. Ultrasound of the upper abdomen will be used to visualize changes in breathing patterns in the chest and blood flow in the abdomen.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03989076
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Interscalene Brachial Plexus Block
Trials testing the same drug.
- NCT04015284 — Intraoperative Pain and Quality of Surgical Block During Shoulder Surgery Assessed by NOL Index · NA · withdrawn
Other University of California, San Diego trials
Trials by the same sponsor.
- NCT07342543 — Guided Physical Activity Counseling for Hypertension in Primary Care · NA · not yet recruiting
- NCT06505317 — Artificial Intelligence for Early Detection of Peripheral Artery Disease · NA · not yet recruiting
- NCT07211802 — CKM For Safe Use of SGLT2i in Type 1 Diabetes · Phase 3 · not yet recruiting
- NCT07524751 — Culturally Adapted Pain Management for Indigenous Peoples · NA · not yet recruiting
- NCT07518784 — Accurate Point of Care Liver Disease Diagnostics (Phase 2) · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03989076 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of California, San Diego
- Last refreshed: 21 July 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03989076.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing